Establishing mathematical models for population growth highlights how plant-based supplements can match the theoretical carrying capacity of full-serum media. As we navigate the bioprocessing landscape of 2026, the reliance on animal-derived components like fetal bovine serum and newborn calf serum
Practical experiments in ethics-integrated education are essential for developing a workforce capable of navigating the moral complexities of modern genetic engineering. As synthetic biology moves from the theoretical confines of academic research into the rapid-fire pace of industrial
The biological hurdles of treating solid tumors with T-cell therapy are being decoded through new findings linking tumor lesion diameters to the ultimate durability of the patient response. At the current Society for Immunotherapy of Cancer Annual Meeting, researchers presented updated data
The complexity of molecular transformations in pharmaceutical synthesis demands enzymes that maintain high selectivity without sacrificing the speed of the chemical reaction. These biological catalysts are the foundation of many life-sustaining processes, yet their natural forms are rarely suited
The global medical supply chain relies heavily on Indian manufacturing, making any shift in domestic pharmaceutical regulations a matter of international concern for healthcare providers and patients alike. The Ministry of Health recently proposed rigorous amendments to the Drugs Rules, signaling a
The Carlsbad facility brings end-to-end viral vector solutions and aseptic fill-finish capabilities to Lonza, catering specifically to the burgeoning cell and gene therapy market. This strategic acquisition of five specialized contract development and manufacturing organization (CDMO) sites from
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47